Pinterest Tyruko News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Food and Drug Administration has recently announced the approval of the first biosimilar treatment for multiple sclerosis, called Tyruko, which provides a potentially more cost-effective alternative to Tysabri.

United statesJoe amonSarah yimPinterest tyrukoSanta monicaBarbara giesserDrug administrationNational multiple sclerosis societyDrugs administrationOffice of therapeutic biologicsDenver postPacific neuroscience instituteProvidence saint johnHealth centerMedical news todayTherapeutic biologics